Skip to content

Serotonin: all studies

Page 311 of 400: studies 3,101 to 3,110 of 3,999, newest first. Back to the serotonin overview

Research

Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs.

Neuropharmacology November 1, 2018 Landon M. Klein, Nicholas V. Cozzi, Paul F. Daley et al. 43 citations

Substantial effort has been devoted toward understanding the psychopharmacological effects of tryptamine hallucinogens, which are thought to be mediated by activation of 5-HT2A and 5-HT1A receptors. Recently, several psychoactive tryptamines based on the N,N-diallyltryptamine (DALT) scaffold have been encountered as recreational drugs. Despite the apparent widespread use of DALT derivatives in...

DOI: 10.1016/j.neuropharm.2018.02.028 (opens in new tab) Full text (opens in new tab) 4-aco-dalt 4-Acetoxy-N,N-Diallyltryptamine 4-Hydroxy-N,N-Diallyltryptamine 5-MEO-Dalt +8

Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.

Neuropharmacology November 1, 2018 Joshua S. Elmore, Ann M Decker, Agnieszka Sulima et al. 59 citations

2,5-Dimethoxyphenethylamines (2C compounds) are 5-HT2A/2C receptor agonists that induce hallucinogenic effects. N-methoxybenzylation of 2C compounds markedly increases their affinity for 5-HT2A receptors, and two such analogs, 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) and 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe),...

DOI: 10.1016/j.neuropharm.2018.02.033 (opens in new tab) Full text (opens in new tab) 5-ht2a receptor Back muscle contractions Wet dog shakes Nbome compounds nbome +8

The Varieties of the Psychedelic Experience: A Preliminary Study of the Association Between the Reported Subjective Effects and the Binding Affinity Profiles of Substituted Phenethylamines and Tryptamines

Frontiers in Integrative Neuroscience November 1, 2018 Camila Sanz, Carla Pallavicini, Carla Pallavicini et al. 78 citations

Classic psychedelics are substances of paramount cultural and neuroscientific importance. A distinctive feature of psychedelic drugs is the wide range of potential subjective effects they can elicit, known to be deeply influenced by the internal state of the user (“set”) and the surroundings (“setting”). The observation of cross-tolerance and a series of empirical studies in humans and animal...

DOI: 10.3389/fnint.2018.00054 (opens in new tab) Full text (opens in new tab) Psychedelics classic psychedelics Hallucinogens Entheogens Psychotropic drugs +17

Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions

Current Molecular Pharmacology October 15, 2018 Ricardo Jorge Dinis-Oliveira, Carolina Lança Pereira, Diana Dias Da Silva 101 citations

Background:Mescaline (3,4,5-trimethoxyphenethylamine), mainly found in the Peyote cactus (Lophophora williamsii), is one of the oldest known hallucinogenic agents that influence human and animal behavior, but its psychoactive mechanisms remain poorly understood.Objective:This article aims to fully review pharmacokinetics and pharmacodynamics of mescaline, focusing on the in vivo and in vitro...

Enhancing Social Interaction in Depression (SIDE study): protocol of a randomised controlled trial on the effects of a Cognitively Based Compassion Training (CBCT) for couples.

BMJ Open October 4, 2018 Corina Aguilar-Raab, Marc N Jarczok, Marco Warth et al.

Introduction: Positive social interactions (PSIs) and stable relationships can exert substantial benefits on health. However, patients suffering from depression benefit less from these health-promoting effects. Moreover, relationship quality and even partners' health has been found to be negatively affected by depressive symptomatology, which may result in overall impairments in social...

Ketamine and Electroconvulsive Therapy for Depression.

Journal of neurosurgical anesthesiology October 1, 2018 C. Andrade

K anesthesia was introduced about half a century ago. In recent decades, this drug, in subanesthetic doses, has also demonstrated efficacy for off-label indications including treating acute and chronic pain, treating agitation, treating depression, and inducing sedation. Thus, there are studies of subanesthetic dosing with ketamine for treating pain in emergency medicine settings, treating...

1/f electrophysiological spectra in resting and drug-induced states can be explained by the dynamics of multiple oscillatory relaxation processes.

Neuroimage October 1, 2018 Suresh Muthukumaraswamy, David Tj Liley

Neurophysiological recordings are dominated by arhythmical activity whose spectra can be characterised by power-law functions, and on this basis are often referred to as reflecting scale-free brain dynamics (1/fβ). Relatively little is known regarding the neural generators and temporal dynamics of this arhythmical behaviour compared to rhythmical behaviour. Here we used Irregularly Resampled...

DOI: 10.1016/j.neuroimage.2018.06.068 (opens in new tab) Full text (opens in new tab) Electrocorticography Electroencephalography Magnetoencephalography Power spectrum +1

Ketamine for Treatment-Resistant Depression: A Gateway to Novel Treatment Approaches

Journal of Psychosocial Nursing and Mental Health Services October 1, 2018 Barbara J. Limandri

Treatment-resistant depression (TRD) is a disabling and demoralizing phenomenon for patients and clinicians. For many years, treatment for depression has relied on the monoamine theory, with medications limited in efficacy and requiring prolonged use before any therapeutic effects are evident. The current article reviews novel approaches to pharmacological treatment of TRD, including...

Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.

Psychopharmacology October 1, 2018 Frederick S. Barrett, Theresa M. Carbonaro, Ethan Hurwitz et al. 109 citations

Classic psychedelics (serotonin 2A receptor agonists) and dissociative hallucinogens (NMDA receptor antagonists), though differing in pharmacology, may share neuropsychological effects. These drugs, however, have undergone limited direct comparison. This report presents data from a double-blind, placebo-controlled within-subjects study comparing the neuropsychological effects of multiple doses...

DOI: 10.1007/s00213-018-4981-x (opens in new tab) Full text (opens in new tab) Mind-altering substance Psilocybin research Psilocybin studies Psychedelic drug psilocybin +17